Table 1 Correlation of clinicopathological features and USP49 expression in pancreatic cancer samples.
 |  | USP49 expression |  | |
---|---|---|---|---|
Characteristic | N | Low | High | p-value |
Gender | Â | Â | Â | 0.4502 |
 Male | 58 | 49 | 9 |  |
 Female | 32 | 25 | 7 |  |
Age(years) | Â | Â | Â | 0.6729 |
 <60 | 49 | 40 | 9 |  |
 ≥60 | 40 | 34 | 6 |  |
Tumor size | Â | Â | Â | 0.0844 |
 T1 | 2 | 2 | 0 |  |
 T2 | 71 | 55 | 16 |  |
 T3–T4 | 16 | 16 | 0 |  |
Pathological grades | Â | Â | Â | 0.0371 |
 I–II (include II) | 57 | 45 | 12 |  |
 II–III (include III) | 32 | 29 | 3 |  |
 III–IV (include IV) | 1 | 0 | 1 |  |
Distant metastasis | Â | Â | Â | 1.000 |
 Absent | 86 | 72 | 14 |  |
 Present | 1 | 1 | 0 |  |
Clinical stages | Â | Â | Â | 0.1779 |
 1 | 37 | 27 | 10 |  |
 2 | 50 | 44 | 6 |  |
 3–4 | 1 | 1 | 0 |  |